These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

396 related items for PubMed ID: 3131814

  • 1. The role of the FDA in the effort against AIDS.
    Young FE.
    Public Health Rep; 1988; 103(3):242-5. PubMed ID: 3131814
    [Abstract] [Full Text] [Related]

  • 2. FDA's proposed regulations to expand access to investigational drugs for treatment use: the status quo in the guise of reform.
    Rossen BR.
    Food Drug Law J; 2009; 64(1):183-223. PubMed ID: 19998746
    [Abstract] [Full Text] [Related]

  • 3. FDA drug classification system.
    Sanborn MD, Godwin HN, Pessetto JD.
    Am J Hosp Pharm; 1991 Dec; 48(12):2659-62. PubMed ID: 1814217
    [Abstract] [Full Text] [Related]

  • 4. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H, Namba K.
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [Abstract] [Full Text] [Related]

  • 5. Original research: Intravenous ribavirin--review of the FDA's Emergency Investigational New Drug Database (1997-2008) and literature review.
    Riner A, Chan-Tack KM, Murray JS.
    Postgrad Med; 2009 May; 121(3):139-46. PubMed ID: 19491552
    [Abstract] [Full Text] [Related]

  • 6. [Diagnostic kits in parasitology: which controls?].
    Rossi P.
    Parassitologia; 2004 Jun; 46(1-2):145-9. PubMed ID: 15305705
    [Abstract] [Full Text] [Related]

  • 7. Investigational new drug, antibiotic, and biological product applications; clinical hold and termination--FDA. Final rule.
    Fed Regist; 1992 Apr 15; 57(73):13244-9. PubMed ID: 10118458
    [Abstract] [Full Text] [Related]

  • 8. Lessons learned from independent central review.
    Ford R, Schwartz L, Dancey J, Dodd LE, Eisenhauer EA, Gwyther S, Rubinstein L, Sargent D, Shankar L, Therasse P, Verweij J.
    Eur J Cancer; 2009 Jan 15; 45(2):268-74. PubMed ID: 19101138
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. FDA's compassion for desperate drug companies.
    Annas GJ.
    Hastings Cent Rep; 1990 Jan 15; 20(1):35-7. PubMed ID: 2179165
    [Abstract] [Full Text] [Related]

  • 13. New drug, antibiotic, and biological drug product regulations; accelerated approval--FDA. Final rule.
    Fed Regist; 1992 Dec 11; 57(239):58942-60. PubMed ID: 10123232
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Medicines for children licensed by the European Agency for the Evaluation of Medicinal Products.
    Ceci A, Felisi M, Catapano M, Baiardi P, Cipollina L, Ravera S, Bagnulo S, Reggio S, Rondini G.
    Eur J Clin Pharmacol; 2002 Nov 11; 58(8):495-500. PubMed ID: 12451425
    [Abstract] [Full Text] [Related]

  • 18. Potent new AIDS drugs underscore promise of combination therapy.
    AIDS Alert; 1996 Jan 11; 11(1):1-4. PubMed ID: 11363225
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.